Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 30, 2005
Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years laterJean-Paul Squifflet, Martine De Meyer, Jacques Malaise, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 15, 2006
Solitary pancreas transplantation for life-threatening allergy to human insulinJacqueline Léonet, Jacques Malaise, Eric Goffin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 9, 2005
Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantationThierry Berney, Jacques Malaise, Philippe Morel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 9, 2005
Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantationDirk R J Kuypers, Jacques Malaise, Kathleen Claes, et al.
Clinical Chemistry and Laboratory Medicine|October 13, 2006
The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal functionMichel Mourad, Pierre Wallemacq, Martine De Meyer, et al.
Transplantation|May 24, 2008
Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcomeMichel Mourad, Pierre Wallemacq, Martine De Meyer, et al.
Canadian Journal of Kidney Health and Disease|March 22, 2017
First Canadian Case Report of Kidney Transplantation From an HIV-Positive Donor to an HIV-Positive RecipientGeorges Ambaraghassi, Héloïse Cardinal, Daniel Corsilli, et al.
Clinical Pharmacokinetics|May 31, 2002
Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?Michel Mourad, Pierre Wallemacq, Josiane König, et al.
Pharmacogenetics|May 29, 2004
The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patientsVincent Haufroid, Michel Mourad, Valérie Van Kerckhove, et al.
Transplant Immunology|May 12, 2007
Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurementDinh Quang Truong, Ahmed A Darwish, Jérémie Gras, et al.
Pageof 3